FRI0082 Ras Signaling Inhibitors Attenuate Arthritis in Animal Models of Rheumatoid Arthritis by Down Modulating the Pathogenic Th17 Cell Response

doi 10.1136/annrheumdis-2017-eular.1083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis via Targeting Pathogenic Antigen-Specific Th17-Type Cells

Frontiers in Immunology
AllergyImmunology
2017English

Rheumatoid Arthritis Bone Marrow Environment Supports Th17 Response

Arthritis Research & Therapy
2017English

Artesunate Influences Th17/Treg Lymphocyte Balance by Modulating Treg Apoptosis and Th17 Proliferation in a Murine Model of Rheumatoid Arthritis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Animal Models of Rheumatoid Arthritis: How Informative Are They?

European Journal of Pharmacology
Pharmacology
2015English

The Pathogenic Role of Angiogenesis in Rheumatoid Arthritis

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2015English

The Pathogenic Role of ACPA in Rheumatoid Arthritis

Japanese Journal of Clinical Immunology
2017English

Dendritic Cell Biology in Animal Models of Arthritis

The Open Arthritis Journal
2010English

Successful Treatment of Animal Models of Rheumatoid Arthritis With Small-Molecule Cyclin-Dependent Kinase Inhibitors

Journal of Immunology
AllergyImmunology
2008English

Metallothionein-1 Suppresses Rheumatoid Arthritis Pathogenesis by Shifting the Th17/Treg Balance

European Journal of Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy